Home

Mission

Resources

Videos

Working Groups

WHAT IS

Heart Valve Collaboratory?

The HVC is a collaborative, multi-disciplinary, patient-centered community of stakeholders addressing complex problems and embracing innovation to help patients with HVD achieve their fullest potential for health. Areas of strategic focus are:

Improving detection of HVD

Decreasing progression of HVD

Optimizing lifetime management strategies for patients with HVD

Identifying knowledge gaps and catalyzing research in the field of HVD

CORE WORKING GROUPS

Knowledge and Evidence Gaps Clinical Trial Design, Regulatory Opportunities, and Implementation Science Research Networks and Collaborations Innovation and Digital Health Underserved Populations and Patient Advocacy

SCIENTIFIC COUNCIL

CO-CHAIRS
PHYSICIANS
GOVERNMENT
INDUSTRY
PATIENT ADVOCATES

MARTIN B. LEON, MD

Co-Chair

MICHAEL J. MACK, MD

Co-Chair

CHANGFU WU, PHD

FDA, Ex Officio

BRAM D. ZUCKERMAN, MD

FDA, Ex Officio

GORAV AILAWADI, MD, MBA

JEROEN J. BAX, MD, PHD

ROBERT O. BONOW, MD

HOWARD C. HERRMANN, MD

MARIELL JESSUP, MD

PATRICK O'GARA, MD

CATHERINE M. OTTO, MD

PHILIPPE PIBAROT, DVM, PHD

VINOD H. THOURANI, MD

SREEKANTH VEMULAPALLI, MD

STEVEN FARMER, MD, PHD

CMS

KATHLEEN FENTON, MD

MIKE DALE

Abbott

TED E. FELDMAN, MD

Edwards Lifesciences

NINA GOODHEART, MBA

Medtronic

IAN MEREDITH, MD, PHD

Boston Scientific

NEIL MOAT, MD

Abbott

JEFF POPMA, MD

Medtronic

LARRY WOOD, MBA

Edwards Lifesciences

JOHN LEWIS

Heart Valve Voice US

OUR POLICY

The Heart Valve Collaboratory (HVC) has an inclusiveness policy, affirming that an inclusive group of volunteers, staff, and associated stakeholders in the heart valve community is essential to our mission. Further, the HVC pledges to continue efforts to broaden its membership so that our Collaboratory is representative of the larger community dedicated to preventing, treating, and surviving heart valve disease.